BD recently announced the launch of its new intraosseous (IO) vascular access system, enabling access for rapid delivery of fluids or medication in critical emergency situations. The procedure involves inserting a needle into the bone marrow cavity when intravenous (IV) access is challenging or delayed.
A press release details that the BD IO system can quickly provide access to the circulatory system for adult and paediatric patients and is built for rapid intervention in varied emergent care environments.
According to BD, this new system is the only IO device on the market that can be placed after the extension set is attached and the only with integrated passive needle tip safety, designed to protect care providers and patients against needlestick injuries.
Clinicians can stabilise the device on the contours of any surrounding anatomy and select from five needle lengths to accommodate a broad range of patients. Unlike other devices on the market, BD notes that the powered driver features a rechargeable battery, which extends the life of the drill up to 12 times when compared to non-rechargeable competitive drills. Additionally, a multi-light battery indicator provides an instant indication of battery status..
“In emergency situations, mistakes and delays can have devastating consequences,” said Eric Borin, worldwide president of medication delivery solutions at BD. “This important innovation represents a significant advancement in rapid vascular access and builds on our ongoing commitment to support medical teams in delivering the highest-quality access and improving patient outcomes during lifesaving emergency health situations.”
BD advises that its IO system is now commercially available to customers in the USA.
